|
ZNF443 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.698200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.094400E-01 |
| Normal-vs-Stage2 |
2.717800E-01 |
| Normal-vs-Stage3 |
2.254100E-02 |
| Normal-vs-Stage4 |
7.754100E-02 |
| Stage1-vs-Stage2 |
8.324000E-01 |
| Stage1-vs-Stage3 |
8.019600E-02 |
| Stage1-vs-Stage4 |
3.111800E-01 |
| Stage2-vs-Stage3 |
3.061600E-01 |
| Stage2-vs-Stage4 |
4.977200E-01 |
| Stage3-vs-Stage4 |
7.529400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.552400E-02 |
| Normal-vs-AfricanAmerican |
4.524100E-02 |
| Normal-vs-Asian |
4.113000E-01 |
| Caucasian-vs-AfricanAmerican |
2.356000E-01 |
| Caucasian-vs-Asian |
7.281500E-03 |
| AfricanAmerican-vs-Asian |
9.941500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.885800E-01 |
| Normal-vs-Female |
4.641700E-02 |
| Male-vs-Female |
2.410200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.955600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.698100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.857600E-02 |
| Normal-vs-Age(81-100Yrs) |
4.631600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.244400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.553800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.357800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.994800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.593800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.564600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.007900E-02 |
| Classical-VS-Follicular |
1.794820E-01 |
| Classical-VS-Other |
5.103000E-01 |
| Classical-VS-Normal |
2.466200E-01 |
| Tall-VS-Follicular |
4.193800E-01 |
| Tall-VS-Other |
1.087840E-01 |
| Tall-VS-Normal |
2.546200E-02 |
| Follicular-VS-Other |
2.886200E-01 |
| Follicular-VS-Normal |
7.248000E-02 |
| Other-VS-Normal |
8.965200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.007900E-02 |
| Normal-vs-N1 |
3.759800E-01 |
| N0-vs-N1 |
5.051200E-01 |
|
|
